TAR-200 plus cetrelimab effective in reducing tumor size in those with muscle-invasive disease, potentially improving surgical outcomes and lowering risk of recurrence In the interim analysis of the ...
In this phase IIb parallel cohort study, patients with BCG-unresponsive carcinoma in situ (CIS) with/without papillary disease received TAR-200 monotherapy (Cohort 2 [C2]), TAR-200 plus cetrelimab (C1 ...
The study is ongoing, and future analyses will include survival outcomes, researchers say. Adding TAR-200 to neoadjuvant treatment with cetrelimab can improve the pathologic complete response (pCR) ...
Getting 200 runs or more in the Indian Premier League (IPL) has always been considered a winning score; however, defending such a high score requires excellent bowling control and composure under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results